Search bioRxivSearch

bioRxiv · 10.1101/272302

The Impact of Spatial Normalization for Functional Magnetic Resonance Imaging Data Analyses Revisited

Abstract

Spatial normalization--the process of aligning anatomical or functional data acquired from different individuals to a common stereotaxic atlas--is routinely used in the vast majority of functional neuroimaging studies, with important consequences for scientific inference and reproducibility. Although several approaches exist, multi-step techniques that leverage the superior contrast and spatial resolution afforded by T1-weighted anatomical images to normalize echo planar imaging (EPI) functional data acquired from the same individuals (T1EPI) is now standard. Yet, recent work suggests that direct alignment of functional data to a T2*-weighted template without recourse to an anatomical image--an EPI only (EPIO) approach--enhances normalization precision. This counterintuitive claim is intriguing, suggesting that a change in standard practices may be warranted. Here, we re-visit these conclusions, extending prior work to encompass newly developed measures of normalization precision, accuracy, and real-world statistical performance for the standard EPIO and T1EPI pipelines implemented in SPM12, a recently developed variant of the EPIO pipeline, and a novel T1EPI pipeline incorporating best practice tools from multiple software packages. The multi-tool T1EPI pipeline was consistently the most precise, most accurate, and resulted in the largest t values at the group level, in some cases dramatically so. The three SPM-based pipelines exhibited more modest and variable differences in performance relative to each another, with the widely used T1EPI pipeline showing the second best overall precision and accuracy, and the recently developed EPIO pipeline generally showing the poorest overall performance. The results demonstrate that standard pipelines can be easily improved and we encourage researchers to invest the resources necessary to do so. The multi-tool pipeline presented here provides a framework for doing so. In addition, the novel performance metrics described here should prove useful for reporting and validating future methods for pre-processing functional neuroimaging data.

Explore related subjects

Keep this discovery

BibTeXRIS

Smith, J. F., Hur, J., Kaplan, C. M., Shackman, A. J.. 2018-02-26. The Impact of Spatial Normalization for Functional Magnetic Resonance Imaging Data Analyses Revisited. https://doi.org/10.1101/272302

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience